A Strategy to Delay the Development of Cisplatin Resistance by Maintaining a Certain Amount of Cisplatin-Sensitive Cells
Abstract Cisplatin (ddp), which is commonly employed in the treatment of many advanced cancers, often results in initial therapeutic success; however, rapid progression of ddp-resistant cells remains the main reason for treatment failure. Facd with such a problem, we investigated the fitness differe...
Guardado en:
Autores principales: | Guihua Duan, Qianyuan Tang, Hongli Yan, Lijuan Xie, Yun Wang, Xi Emily Zheng, Yuzheng Zhuge, Shanshan Shen, Bin Zhang, Xiaoqi Zhang, Jun Wang, Wei Wang, Xiaoping Zou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a691dcdfe7174ca6ac4ff787ab00831c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
por: Zhen Zeng, et al.
Publicado: (2018) -
Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
por: Khan MM, et al.
Publicado: (2020) -
Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
por: Ma Y, et al.
Publicado: (2019) -
Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity
por: Masashi Arita, et al.
Publicado: (2021) -
Pretreatment of Huaiqihuang extractum protects against cisplatin-induced nephrotoxicity
por: Yujiao Guo, et al.
Publicado: (2018)